Oceania Healthcare Limited (NZE:OCA)
New Zealand
· Delayed Price · Currency is NZD 0.6000
0.00 (0.00%)
Jun 6, 2025, 5:00 PM NZST
Oceania Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 260.57 | 265.46 | 247.18 | 231.14 | 210.5 | Upgrade
|
| Other Revenue | - | - | - | - | 2.45 | Upgrade
|
| Revenue | 260.57 | 265.46 | 247.18 | 231.14 | 212.95 | Upgrade
|
| Revenue Growth (YoY) | -1.84% | 7.40% | 6.94% | 8.54% | 8.52% | Upgrade
|
| Cost of Revenue | 178.37 | 178.79 | 164.48 | 156.45 | 138.87 | Upgrade
|
| Gross Profit | 82.2 | 86.68 | 82.7 | 74.69 | 74.08 | Upgrade
|
| Selling, General & Admin | - | - | 0.16 | 2.5 | 4.94 | Upgrade
|
| Other Operating Expenses | 81.41 | 77.23 | 66.78 | 59.99 | 56.91 | Upgrade
|
| Operating Expenses | 103.56 | 96.22 | 84.86 | 81.11 | 78.09 | Upgrade
|
| Operating Income | -21.36 | -9.54 | -2.17 | -6.42 | -4.01 | Upgrade
|
| Interest Expense | -20.83 | -10.9 | -9.12 | -5.76 | -4.27 | Upgrade
|
| Interest & Investment Income | 3.11 | 4.54 | 1.76 | 0.08 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.82 | -3.59 | -2.86 | -0.19 | -3.88 | Upgrade
|
| EBT Excluding Unusual Items | -37.25 | -19.48 | -12.38 | -12.29 | -12.14 | Upgrade
|
| Impairment of Goodwill | -0.2 | -0.56 | -2.35 | -0.41 | -1.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.85 | -5.77 | 2.63 | -0.03 | 0.1 | Upgrade
|
| Asset Writedown | 64.16 | 51.51 | 13.48 | 58.62 | 103.84 | Upgrade
|
| Other Unusual Items | - | - | -1.4 | 10.36 | - | Upgrade
|
| Pretax Income | 25.85 | 28.39 | 12 | 56.25 | 90.34 | Upgrade
|
| Income Tax Expense | -4.56 | -3.08 | -3.45 | -4.88 | -12.48 | Upgrade
|
| Net Income | 30.42 | 31.47 | 15.45 | 61.13 | 102.82 | Upgrade
|
| Net Income to Common | 30.42 | 31.47 | 15.45 | 61.13 | 102.82 | Upgrade
|
| Net Income Growth | -3.36% | 103.74% | -74.73% | -40.54% | - | Upgrade
|
| Shares Outstanding (Basic) | 724 | 723 | 715 | 705 | 622 | Upgrade
|
| Shares Outstanding (Diluted) | 724 | 724 | 716 | 705 | 622 | Upgrade
|
| Shares Change (YoY) | 0.08% | 1.12% | 1.46% | 13.49% | 1.77% | Upgrade
|
| EPS (Basic) | 0.04 | 0.04 | 0.02 | 0.09 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.04 | 0.02 | 0.09 | 0.17 | Upgrade
|
| EPS Growth | -2.33% | 99.12% | -75.08% | -47.61% | - | Upgrade
|
| Free Cash Flow | 70.04 | 50.17 | 14.1 | 49.23 | 71.72 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.07 | 0.02 | 0.07 | 0.12 | Upgrade
|
| Dividend Per Share | - | - | 0.032 | 0.044 | 0.041 | Upgrade
|
| Dividend Growth | - | - | -27.27% | 7.84% | 16.57% | Upgrade
|
| Gross Margin | 31.55% | 32.65% | 33.46% | 32.31% | 34.79% | Upgrade
|
| Operating Margin | -8.20% | -3.59% | -0.88% | -2.78% | -1.88% | Upgrade
|
| Profit Margin | 11.67% | 11.86% | 6.25% | 26.45% | 48.28% | Upgrade
|
| Free Cash Flow Margin | 26.88% | 18.90% | 5.71% | 21.30% | 33.68% | Upgrade
|
| EBITDA | -2.34 | 6.78 | 13.02 | 9.02 | 9.5 | Upgrade
|
| EBITDA Margin | -0.90% | 2.55% | 5.27% | 3.90% | 4.46% | Upgrade
|
| D&A For EBITDA | 19.02 | 16.32 | 15.19 | 15.44 | 13.51 | Upgrade
|
| EBIT | -21.36 | -9.54 | -2.17 | -6.42 | -4.01 | Upgrade
|
| EBIT Margin | -8.20% | -3.59% | -0.88% | -2.78% | -1.88% | Upgrade
|
| Revenue as Reported | 355.68 | 335.41 | 285.97 | 308.48 | 311.7 | Upgrade
|
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.